Effect of counterions on the physical properties of l-arginine in frozen solutions and freeze-dried solids

Akers, 1995, Glycine crystallization during freezing: the effects of salt form, pH, and ionic strength, Pharm. Res., 12, 1457, 10.1023/A:1016223101872 Anchordoquy, 2001, Maintenance of quaternary structure in the frozen state stabilizes lactate dehydrogenase during freeze-drying, Arch. Biochem. Biophys., 390, 35, 10.1006/abbi.2001.2351 Aoki, 1971, The crystal structure of l-arginine phosphate monohydrate, Acta Cryst., B27, 11, 10.1107/S056774087100164X Arakawa, 2003, The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation, Biochem. Biophys. Res. Commun., 304, 148, 10.1016/S0006-291X(03)00578-3 Brulls, 2003, In situ near-infrared spectroscopy monitoring of the lyophilization process, Pharm. Res., 20, 494, 10.1023/A:1022680810474 Buchner, 1991, Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli, Biotechnology (NY), 9, 157, 10.1038/nbt0291-157 Carpenter, 1997, Rational design of stable lyophilized protein formulations: some practical advice, Pharm. Res., 14, 969, 10.1023/A:1012180707283 Chang, 1992, Use of thermal analysis to optimize protein lyophilization, Cryobiology, 29, 632, 10.1016/0011-2240(92)90067-C Chilson, 1965, Studies on the mechanism of hybridization of lactic dehydrogenase in vitro, Biochemistry, 4, 271, 10.1021/bi00878a015 Craig, 1999, The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze-dried systems, Int. J. Pharm., 179, 179, 10.1016/S0378-5173(98)00338-X Dow, 1970, Refinement of the structure of arginine hydrochloride monohydrate, Acta Cryst., B26, 1662, 10.1107/S0567740870004697 Franks, 1998, Freeze-drying of bioproducts: putting principles into practice, Eur. J. Pharm. Biopharm., 45, 221, 10.1016/S0939-6411(98)00004-6 Hancock, 1997, Characteristics and significance of the amorphous state in pharmaceutical systems, J. Pharm. Sci., 86, 1, 10.1021/js9601896 Hsu, 1995, Surface denaturation at solid-void interface—a possible pathway by which opalescent particulates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures, Pharm. Res., 12, 69, 10.1023/A:1016270103863 Izutsu, 2003, Effect of sodium tetraborate (borax) on the thermal properties of frozen aqueous sugar and polyol solutions, Chem. Pharm. Bull., 51, 663, 10.1248/cpb.51.663 Izutsu, 1991, The effects of additives on the stability of freeze-dried β-galactosidase stored at elevated temperature, Int. J. Pharm., 71, 137, 10.1016/0378-5173(91)90075-Y Izutsu, 1993, Decreased protein-stabilizing effects of cryoprotectants due to crystallization, Pharm. Res., 10, 1232, 10.1023/A:1018988823116 Kamat, 1989, Near-infrared spectroscopic determination of residual moisture in lyophilized sucrose through intact glass vials, Pharm. Res., 6, 961, 10.1023/A:1015997530367 Kawai, 2002, Glass transition and enthalpy relaxation of polyphosphate compounds, Cryo Lett., 23, 79, 10.1016/S0304-3835(02)00161-1 Lin, 2002, Determination of residual moisture in lyophilized protein pharmaceuticals using a rapid and non-invasive method: near infrared spectroscopy, PDA J. Pharm. Sci. Technol., 56, 196 Mattern, 1999, Formulation of proteins in vacuum-dried glasses, II. Process and storage stability in sugar-free amino acid systems, Pharm. Dev. Technol., 4, 199, 10.1081/PDT-100101354 Mazumder, 1995, Infrared spectroscopy and thermal studies of as-grown l-arginine phosphate monohydrate crystals, Jpn. J. Appl. Phys., Part 1, 34, 5717, 10.1143/JJAP.34.5717 Meera, 2004, Growth of nonlinear optical material: l-arginine hydrochloride and its characterisation, J. Cryst. Growth, 263, 510, 10.1016/j.jcrysgro.2003.11.093 Miller, 1999, Viscosity and glass transition temperature of aqueous mixtures of trehalose with borax and sodium chloride, J. Phys. Chem., B103, 10243, 10.1021/jp984736i Mumenthaler, 1994, Feasibility study on spray-drying protein pharmaceuticals: recombinant human growth hormone and tissue-type plasminogen activator, Pharm. Res., 11, 12, 10.1023/A:1018929224005 Nail, 2002, Fundamentals of freeze-drying, Pharm. Biotechnol., 14 Ohtake, 2004, Effect of sugar-phosphate mixtures on the stability of DPPC membranes in dehydrated systems, Cryobiology, 48, 81, 10.1016/j.cryobiol.2004.01.001 Ozaki, 1996 Prestrelski, 1993, Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. II. Structural studies using infrared spectroscopy, Arch. Biochem. Biophys., 303, 465, 10.1006/abbi.1993.1310 Rudolph, 1979, Reconstitution of lactic dehydrogenase. Noncovalent aggregation vs. reactivation. 2. Reactivation of irreversibly denatured aggregates, Biochemistry, 18, 5572, 10.1021/bi00592a008 Seguro, 1990, Cryoprotective effect of sodium glutamate and lysine-HCl on freeze denaturation of lactate dehydrogenase, Cryobiology, 27, 70, 10.1016/0011-2240(90)90053-7 Shalaev, 1995, Structural glass transition and thermophysical processes in amorphous carbohydrates and their supersaturated solutions, J. Chem. Soc. Faraday Trans., 91, 1511, 10.1039/ft9959101511 Shamblin, 1998, Mixing behavior of colyophilized binary systems, J. Pharm. Sci., 87, 694, 10.1021/JS9704801 Shiraki, 2002, Biophysical effect of amino acids on the prevention of protein aggregation, J. Biochem. (Tokyo), 132, 591, 10.1093/oxfordjournals.jbchem.a003261 Taneja, 1994, Increased thermal stability of proteins in the presence of amino acids, Biochem. J., 303, 147, 10.1042/bj3030147 Tong, 2002, Influence of alkali metal counterions on the glass transition temperature of amorphous indomethacin salts, Pharm. Res., 19, 649, 10.1023/A:1015310213887 Wolkers, 2004, Preservation of dried liposomes in the presence of sugar and phosphate, Biochim. Biophys. Acta, 1661, 125, 10.1016/j.bbamem.2003.12.006 Zettlmeissl, 1979, Reconstitution of lactic dehydrogenase. Noncovalent aggregation vs. reactivation. 1. Physical properties and kinetics of aggregation, Biochemistry, 18, 5549, 10.1021/bi00592a007 Zhang, 1996, The effect of the reconstitution medium on aggregation of lyophilized recombinant interleukin-2 and ribonuclease A, Pharm. Res., 13, 643, 10.1023/A:1016074811306